| ²é¿´: 2107 | »Ø¸´: 7 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
lairongpengÒø³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
Çó½Ì¾³£¿´Ó¢ÎÄÎÄÏ׵ĴóÉñ£¬ÕâЩÊÇɶÒâË¼ÄØ£¿
|
|
|
pyrG89; wA3; pyroA4 [pyr4 + copA::gfp] (pyrG89; pyroA4; nkuA::argB) pAL12-Lifeact [Ptef-1::Lifeact-TagRFP-T::nat1] sepA::sGFPpyrG89;argB2;¦¤bemA::argB;sE15,fwA1(¦¤nkuB::pyrG;nkuA;argB;uaY9) |
» ²ÂÄãϲ»¶
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖеÄȤÊ£ºÊµÑéÆ÷²ÄµÄ ¡°ÎÚÁú¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖеÄȤÊ£ººÍʵÑé²ÄÁ쵀 ¡°¶·ÖǶ·Ó¡±
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ231È˻ظ´
µ°°×Öʼì²â£º¾«×¼·ÖÎö£¬½âËøÉúÎï·Ö×ÓµÄÃÜÂë
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑé֮СÊóʵÑ飺ÑϽ÷Éè¼Æ£¬½âÎöÉúÃü»úÖÆµÄÖØÒªÔØÌå
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®ÖØ½ðÊô¼ì²â£º¾«×¼É¸²é£¬ÊØ»¤½¡¿µÓë»·¾³µÄ·ÀÏß
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÍܲâÖØ½ðÊôÎÒ±³¹øÈýǧ¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÊóÌÓÈý´ÎÎÒ·¢ÈýƪSCI¡±
ÒѾÓÐ0È˻ظ´
ÄÉÃ×Á£¶È·ÖÎö
ÒѾÓÐ3È˻ظ´
ÁÖ¿ÆÔºÁÖ»¯ËùÕÐÊÕ²ÄÁÏÓ뻯¹¤×¨ÒµË¶Ê¿£¬×ø±êÄϾ©
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
²ÄÁÏרҵ¿´Ó¢ÎÄÎÄÏ×ÓÐûÓÐרҵµÄ×Öµä»òÍøÕ¾¿É¹©·Òë
ÒѾÓÐ12È˻ظ´
±¾ÈËÓ¢Óï²»ºÃ£¬ÐèÒªÏÂÃæµÄÓ¢ÎÄ×ÊÁÏ£¬Çó´óÉñ·ÒëÁ½¶ÎÎÄÏס£¸Ð¼¤²»¾¡£¡£¡
ÒѾÓÐ3È˻ظ´
Ó¢ÎÄÎÄÏ×ÖÐËùÊöµÄÕâÖÖͳ¼Æ·ÖÎö·½·¨ÊÇʲôÒâ˼
ÒѾÓÐ3È˻ظ´
ÇóÖúÓ¢ÎÄÎÄÏ׵ľßÌå¸ñʽÊÇʲôÒâ˼
ÒѾÓÐ4È˻ظ´
һЩӢÎÄÔÖø£¬ÎÄÏ׿´µÃÓÐЩ³ÔÁ¦£¬´ó¼ÒÓÐʲôºÃ°ì·¨£¿
ÒѾÓÐ23È˻ظ´
Ó¢ÎÄÎÄÏ×ÀïÃæ¾³£ÔÚÃèÊöʵÑé²Ù×÷ʱ£¬Óá°extract¡±Õâ¸ö¶¯´Ê£¬ÊÇÝÍÈ¡µÄÒâ˼Âð£¿
ÒѾÓÐ4È˻ظ´
µ½ÄÄÀïÄܹ»ÕÒµ½ºÃµÄÖÐÎÄÎÄÏ× ÎÒÊǶíÓïÉú Ö»»á¶íÓï Ó¢ÎÄÎÄÏ׿´²»¶® Çó´óÉñ°ïæ
ÒѾÓÐ18È˻ظ´
Ó¢Îĺõİï°ïæ°¡£¬stillżÁª·´Ó¦µÄºó´¦Àí£¬Ó¢ÎÄÎÄÏ×Öеļ¸¾ä¿´²»¶®°¡£¡£¡£¡
ÒѾÓÐ11È˻ظ´
Çó½Ì»ùÒòdefeciencyÊÇʲôÒâ˼
ÒѾÓÐ4È˻ظ´
Çó½Ì¸÷λ´óÉñ£¬×öOLED²ÄÁÏÈç¹ûûÓÐ×ö³ÉÆ÷¼þ²âÊÔÐÔÄÜ£¬ÄÜ·¢Ê²Ã´µµ´ÎµÄÎÄÕÂ
ÒѾÓÐ7È˻ظ´
Çó´óÉñ°ï·ÒëÓ¢ÎÄÎÄÏ×
ÒѾÓÐ4È˻ظ´
±íÃæ»îÐÔ¼Á¸´ÅäµÄÓ¢ÎÄÎÄÏ×ÖÐunlike interactionsºÍlike interactionsÊÇʲôÒâ˼°¡£¿
ÒѾÓÐ7È˻ظ´
Çó½Ì£¬ºÜ¶àÓ¢ÎÄÎÄÏ×É϶¼ÓÐSCAN-CM XX:XX Õâ¸öÊÇʲôÒâ˼°¢ ÄÜÏÂÔØµ½Âð
ÒѾÓÐ3È˻ظ´
ÒÔǰµÄÓ¢ÎÄÎÄÏ×ÀïÃæpart sÊÇʲôÒâ˼
ÒѾÓÐ3È˻ظ´
Çë½Ìһϸ÷λţÈË£¬Ò½Ñ§ÀàµÄÓ¢ÎÄÎÄÏ×Ò»°ãÓÃʲô·Ò빤¾ß±È½Ï×¼È·ÄØ£¿
ÒѾÓÐ9È˻ظ´
Ó¢ÓïÂÛÎÄÖÐÒýÓÃÖÐÎÄÎÄÏ׿ÉÒÔÂð
ÒѾÓÐ4È˻ظ´
Çë½Ì¿ªÊ¼¿´Ó¢ÎÄÎÄÏ׵ķ½·¨
ÒѾÓÐ12È˻ظ´
У¶ÔÒâ¼ûÖС°ÖÐÎĵÄÎÄÏ×ÄÚÈÝÒªÓÐÏà¶ÔÓ¦µÄÓ¢ÎÄ·Ò롱ÊÇʲôÒâ˼£¬¼±£¡
ÒѾÓÐ3È˻ظ´
ÇóÖú½âÎöÓ¢ÎIJο¼ÎÄÏ×´ú±íµÄÒâ˼£¿
ÒѾÓÐ6È˻ظ´
¡¾½»Á÷¡¿¿´Ó¢ÎÄÎÄÏ׺ÃÄѰ¡
ÒѾÓÐ42È˻ظ´
¡¾ÇóÖú¡¿ÇëÎÊ£¬²ÄÁÏ·½ÃæÓ¢ÎÄÎÄÏ×ÖеÄself-textureÊÇʲôÒâ˼
ÒѾÓÐ4È˻ظ´
lairongpeng
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 15 (СѧÉú)
- ½ð±Ò: 1163.6
- É¢½ð: 58
- ºì»¨: 1
- Ìû×Ó: 374
- ÔÚÏß: 159Сʱ
- ³æºÅ: 2428081
- ×¢²á: 2013-04-20
- ÐÔ±ð: GG
- רҵ: ΢ÉúÎïÒÅ´«ÓýÖÖѧ
7Â¥2013-09-11 18:56:04
jlc0225
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 18984.5
- ºì»¨: 2
- Ìû×Ó: 1681
- ÔÚÏß: 146.6Сʱ
- ³æºÅ: 590390
- ×¢²á: 2008-08-31
- ÐÔ±ð: MM
- רҵ: ÉúÎﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
http://www.nature.com/nprot/jour ... ot.2007.112_T2.html Pyridoxine (ANM plus NH4, riboflavin and biotin) medium allows growth (pyroA+) versus no growth (pyroA4) to be scored |

2Â¥2013-09-03 15:48:03
lairongpeng
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 15 (СѧÉú)
- ½ð±Ò: 1163.6
- É¢½ð: 58
- ºì»¨: 1
- Ìû×Ó: 374
- ÔÚÏß: 159Сʱ
- ³æºÅ: 2428081
- ×¢²á: 2013-04-20
- ÐÔ±ð: GG
- רҵ: ΢ÉúÎïÒÅ´«ÓýÖÖѧ
|
Äܲ»ÄÜÂé·³Äã½âÊÍÒ»ÏÂÄØ£¿±ÈÈçÕâÊÇÔÚһƪPNASÎÄÏ×Öп´µ½µÄ¡£²»ÖªµÀʲôÒâ˼£ºThe A. nidulans reference strain was FGSC 4A. Gene deletions in A. nidulans were carried out by transforming FGSC A1149 (pyrG89; pyroA4; nkuA::argB) by established protocols.ÆäÖУ¬(pyrG89; pyroA4; nkuA::argB) ÊÇʲôÒâË¼ÄØ£¿ |
3Â¥2013-09-03 19:30:28
jlc0225
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 18984.5
- ºì»¨: 2
- Ìû×Ó: 1681
- ÔÚÏß: 146.6Сʱ
- ³æºÅ: 590390
- ×¢²á: 2008-08-31
- ÐÔ±ð: MM
- רҵ: ÉúÎﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
kx444555: ½ð±Ò+3, ¹ÄÀø½»Á÷ 2013-09-04 15:23:07
kx444555: ½ð±Ò+3, ¹ÄÀø½»Á÷ 2013-09-04 15:23:07
|
http://www.fgsc.net/scripts/Stra ... age.asp?OrgID=11562 Lesion: pyrG89 pyrimidine req. orotidine MP decarboxylase Enzyme Name: orotidine 5'-monophosphate decarboxylase Lesion Information for Marker: Linkage Group of pyrG89: IL Marker description or requirements: Optimal supplementation is 2.5 mg/ml (10 mM) each of uridine + uracil. pyrG89is cold sensitive and sectors Reference for: pyrG89: 10167. de Souza et al. 1998. Curr. Genet. 33,60-69 Reference for: pyrG89: 10472. Oakley, B. R. et al. 1987. Gene 61;385-399 Reference for: pyrG89: 10486. Palmer, L. M. & D. J. Cove 1975. Mol. Gen. Genet. 138,243-255. Lesion: pyroA4 pyridoxine req. Lesion Information for Marker: Linkage Group of pyroA4: IVR Marker description or requirements: Responds to pyridoxine Reference for: pyroA4: 10332. Kafer, E. 1958. Adv. Genet. , 9,105. Lesion: nkuA::argB Marker description or requirements: Arginine requirement. The nkuA gene was deleted in KJ12 by replacing it with argB. This was crossed to A770. TN02A7 is a segregant of this cross. Deletion of the nkuA (the A. nidulans homolog of human Ku70 gene) reduces the frequency of non-homologous integration of transforming DNA and greatly facilitates gene targeting. NkuA deleted strains show no obvious growth defect and are not sensitive to a variety of DNA damaging drugs. |

4Â¥2013-09-04 09:07:52













»Ø¸´´ËÂ¥